There is concern about the potential misuse of GLP-1 weight-loss drugs, such as Ozempic, particularly among individuals with eating disorders. The impact of these drugs on older adults is also being examined, with possible effects including bone loss in women during menopause. The relationship between GLP-1s and eating disorders, as well as their overall effect on older populations, appears to be a topic of discussion and study.